Coagulation Flashcards

1
Q

What initiates primary hemostasis?

A

Exposure of subendothelial collagen following injury to the vessel wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anticoagulant properties of intact endothelium

A
  • prostacyclin (PLT inhibitor)
  • nitric oxide (vascular relaxing)
  • heparin sulfate
  • tissue factor pathway inhibitor (suppress extrinsic pathway)
  • tissue plasminogen activator (activate fibrinolysis)
  • smooth continuous surface (inert)
  • expression of endothelial protein C receptors (inactivates Va, VIIIa)
  • expression of cell membrane thrombomodulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pro-coagulant properties of damaged vasculature:

A
  • exposure of subendothelial connective tissue (collagen binds vWF and PLT)
  • vasoconstriction caused by harm
  • secretion of vWF from endothelial cells and regulation of PLT and leukocyte receptors
  • subendothelial cells (smooth muscle and fibroblasts contain tissue factor and FIII
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

This is a reversible process where pots binds to subendothelial collagen

A

Adhesion
- need vWF to promote or initiate activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The bridge between PLT and collagen

A

VWF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When PLTs bind each other to form PLT plug

A

Aggregation
- blocks site of injury
- induced by ADP released from PLTs from adhesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Function of ADP in aggregation

A
  • induces it
  • exposes fibrinogen receptor sites on the PLT membrane (GPIIb/IIIa)
  • up-regulates p-selection to surface of PLT = now PLT can absorb fibrinogen from plasma and aggregate with PLTs that have adhered to wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T or F. Fibrinogen binding is a calcium-dependent process

A

T!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GPIIb/IIIa deficiency/calcium/ fibrinogen deficiency =

A

Defective platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

granule secretion is simultaneous with this step

A

aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which granules promote irreversible aggregation?

A

TxA2, ADP, thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

1st wave vs 2nd wave of granule secretion

A

1st wave = reversible, loose agg
2nd wave = stronger stimulus; irreversble

plug stabilized via fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

thromboxane A2 function

A

Ca2+ release
vasoconstriction
PLT agg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

dense plt granules

A
  • fuse with plasma membrane to secrete contents
  • contains small molecules: ADP, ATP, Ca, Mgm serotonin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADP

A

promotes agg
same with Ca and Mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

prolongs vasoconstriction

A

serotonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

alpha plt granules

A

secrete contents into surface-connected canalicular system that releases contents to external environment
- contains large molecules: PF4, PDGF, B thromboglobulin, endothelial GF, transforming GF, factors V, XI, vWF, fibronogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Inactive form of an enzyme

A

Zymogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Serine protease

A

Active form of clotting factor whose activity depend on the amino acid serine at activation site; serine proteases hydrolyze peptide bonds at specific cleavage site to convert the next factor into another serine protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The Serine protease are…

A

Kallikrein
Factor IIa
VIIa
IXaa
Xa
XIa
XIIa
Plasminogen
Protein C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What does vit K do?

A

Catalyses the carbosylation of the amino-terminal glutamic acids
- carbonyl groups can then bind calcium and allow for the binding of platelet factor 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which coat factors are vitamin K dependent?

A

II (prothrombin)
VII
IX
X
Protein C, S, Z

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

These laces are particularly rich in tissue factor

A

Placenta, brain
Lungs
Thymus

TF = protein + phospholipid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is PF3?

A

Membrane phospholipid on platelets
Becomes exposed when PLTs are activated
Catalytic surface; localized environment for activation of clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
T or F. PT pathway is really slow
T! Will feedback and activate more of the PTT coat factors (does more of the work)
26
Role of vWF
- carrier and stabilizes VIIIC - adhesion of PLTs to subendothelium - ristocetin agg of PLT
27
In-Vito hemostasis
TWO phases 1. Initiation = on TF bearing cell; FCIIa + TF activates X and IX; Xa/Va activates small amounts of thrombin 2. Propagation = large amts of thrombin on PLT; XIa binds activated PLT and IX -> IXa
28
Thrombin function
Activates PLT, Va, VIIIa, XIa, fibrinogen to fibrin
29
FVII does not just activate FX, it also activates…
IX and VIII
30
Without _____, FVIII is very labile
VWF
31
Which factor dissociates FVIII from vWF
Thrombin
32
Tenase complex
Active form of IX going to form more factor X; composed of FIX, VIII, PL on platelet surface
33
Prothrombinase complex
FXa combines to form this; with FV and PL = creates a burst of thrombin = promotes feedback into loop
34
Inhibitor and regulatory mechanisms of coagulation
- fibrinolytic system - tissue factor pathway inhibitor Protein C system Anti-thrombin - protein Z-dependent protease inhibitor
35
Components of the fibrinolytic system
Plasminogen TPA Urokinase Plasminogen activator inhibitor 1 Alpha 2 anti plasmin Thrombin-activatable fibrinolysis inhibitor
36
Source of tpa
Damaged endothelial cells
37
What is plasminogen
Breaks down fibrin polymers to FDPs - can digest both fibrin and fibrinogen - digests FV, FVIII - causes 1st fibrinolysis PREVENTED BY alpha-2-antiplasmin
38
TPA function
- binds plasminogen and initiates digestion - circulating TPA bound by inhibitors (PAI-1) - recombinant TPA used to dissolve clots
39
Urokinase
Prevents clot formation in extra-renal collecting system - incorpated into clot along w plasminogen & TPA - activated in presence of fibrin and plasmin
40
Plasminogen activator inhibitor 1
- primary inhibitor of plasminogen activation - inactivates TPA and urokinase - prevents conversion of plasminogen to plasmin - present in excess of TPA, binds circulating TPA
41
Alpha 2 anti-plasmin
- 1ry inhibitor of free plasmin - rapidly and irreversibly binds free plasmin -slows down digestion of clot
42
Primary inhibitor of plasminogen
PAI-1
43
TAFI
- thrombin-activatable fibrinolysis inhibitor - inhibits fibrinolysis by cleaving plasminogen/tPA binding sites on fibrin - prevent plasmin formation and fibrinolysis
44
Marker of thrombosis and fibrinolysis
D-dimmers -X-linked fibres cleaved by plasmin
45
How can fragments inhibit hemostasis and contribute to hemorrhage?
It prevents PLT cit action and also hinders fibrin polymerization
46
TFPI
TISSUE FACTOR PATHWAY INHIBITOR - 80%% bound, rest circulates - inhibits coagulation by inactivating FXa; binds FXa & inactivates TF:FVIIa - protein S = co-factor - TF pathway short-lived
47
Protein C system
- activated thrombin binds thrombomodulin (endothelial membrane protein) - thrombin + thrombomodulin = conformational change in thrombin = loses pro-coat properties - this complex activates protein C - APC combines with protein S - APC + PS = inactivates FVa, FVIIIa - APC promotes fibrinolysis (binds PAI-1)
48
Anti-thrombin
- inhibits FII, IX, X, XI, XII, Kallikrein, plasmin - activated by heparin from mast cell granules and hep. Sulfate on endo cells - therapeutic heparin increases activity of AT 1000x = potent inhibitor of coagulation
49
Protein Z dependent protease inhibitor
- inhibits FXa, FXIa (degrade) - binds cofactor protein Z and FXa with PL and Ca 2+ = accelerated by heparin - vit K dependent!
50
Bernard Soulier
- aut recessive - allows binding of vWF to bring PLT closer to collagen - deficiency = adhesion problems - ristocetin induces this process that we can use for aggregation studies in vitro
51
Bernard Soulier lab test results
- normal PT/PTT - n to increased PLTs - bleeding time increased - PLT agg studies > neg with ristocetin > decreased w thrombin > N w ADP, epi, collagen (don’t use GPIb)
52
Glanzman’s Thrombasthenia
- aut recessive - GPIIb/IIIa allows fibrinogen to cross link PLT - deficiency of the receptor leads to defective aggregation and bleeding issues
53
Glanzman’s lab test results
- normal PT/PTT and PLT # - increased bleeding time - PLT agg studies = normal with ristocetin only; neg with all other
54
Method to study dense granules
- electron microscopy - genetic studies
55
Dense granule deficiency
- non-albinism = granule membrane there but no condense; inability to package; mild bleeding; PLT agg = prolonged - albinism = Chediak Higashi; profound granule def; no response
56
Alpha granule deficiency
- auto recessive - agranular appearance (can see in PBS) - grey PLT syndrome - prolonged BT and decreased PLT count and slightly larger in size
57
VWF disease
- autosomal dominant - mutations in vWF gene (qual or quant) - bleeding probs due to abnormal PLT adhesion - usually accompanied by FVIII:c deficiency - disease severity varies (depending on homogeneity) - bleeding usually mucocutaneous (easy bruising, nosebleeds, etc.) - less vWF = type O blood
58
VWF disease usually accompanied by a deficiency in
Factor VIII
59
VWF disease lab test results
- PLT agg = ristocetin variable and others = normal - PT/PTT = N; PTT may be increased - PLT - N - BT = prolonged - ristocetin co-factor assay = no aggregation
60
Treatment for vWF disease
Desmopressin - triggers release of vWF from endothelial cells or give recombinant vWF
61
Hemophilia A
- F8 def - X-linked recessive - may have Abs to FVIII or FVIII:c - PTT prolonged; TT = normal; inhibitor screen may be abnormal; BT = normal - FVIII assay to tell severity of disease
62
F9 deficiency
Hemophilia B - X-linked recessive - Christmas - prolonged PTT - normal BT and TT
63
F11 def
Hemophilia C - aut dominant - prolonged PTT - normal BT, TT - inhibitors = normal
64
FV Leiden mutation
- aut dom thrmobophilia - single pt mutation that removes APC binding site on FV (APC cannot inactivate it) = thrombosis/increased clots - clot-based assay to screen; DNA/genetic studies for confirmation
65
Prothrombin G20210A
- inherited thrombophilia - elevated plasma prothrombin concentration - increase rick of thrombosis - DNA/genetic studies/PCR to diagnose
66
Acquired thrombotic disorder - lupus anticoagulant/antiphospholipid
- non-specific inhibitor - binds protein-phospholipid complex in PTT reagent - no- in-vivo effects - patients prone to stroke and DVT - everything prolonged; but viper venom normal and mixing studies no correction
67
Causes of a quad factor deficiencies
- liver disease - vit. K deficiency = no carboxylation and activation - autoantibodies = inhibits action of coat factors ; FVIII most common (SLE, pregnancy, idiopathic, etc.) NOTE -results not corrected in mixing studies ; corrected using diluted samples which dilute out inhibitor activity
68
Treatment for autoantibodies
Immunosuppressants
69
Sample requirements
- sodium citrate - filled to capacity - 1:9 anticoag:sample - do not heat or freeze - can freeze plasma
70
Benefits of sodium citrate
- preserves V, VIII - stabilizes pH - does not inhibit PLT function - easily reversed with calcium
71
Why isn’t EDTA used in coat testing
- does not preserve FV - interferes with fibrin polymerization
72
Why isn’t heparin used in coag testing
- activates anti-thrombin - prolongs results
73
Normal results in D-dimmer testing rules out…
DIC, DVT, PE